Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phrase 'Multiple immune and non-immune cell populations via cell-cell contact and secretome' does not identify a specific molecular target but rather describes a complex biological system of cellular communication. It refers to the multifaceted interactions between various cell types, such as lymphocytes, macrophages, fibroblasts, and endothelial cells, which are mediated through direct physical contact and the release of soluble factors known as the secretome (Alberts B, et al. Molecular Biology of the Cell, 2014). Cell-cell contact involves membrane-bound ligand-receptor interactions that trigger intracellular signaling, while the secretome consists of cytokines, chemokines, and growth factors that act in a paracrine or autocrine fashion (Makridakis M, et al. J Proteomics, 2013). This terminology is often used to characterize the broad, pleiotropic effects of cell-based therapies, such as mesenchymal stem cells, which modulate the immune microenvironment through these combined mechanisms (Vizoso FJ, et al. Int J Mol Sci, 2017). Because it encompasses a wide array of molecules and cellular processes, it lacks the specificity required to be classified as a discrete therapeutic target in drug development. Consequently, it represents a description of a biological phenomenon or a drug's mechanism of action rather than a single druggable protein or receptor.
Not applicable as this is a description of a biological process rather than a molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple immune and non-immune cell populations via cell-cell contact and secretome.